Your session is about to expire
← Back to Search
Probiotic
Probiotics for Knee Replacement (GUMBO Trial)
N/A
Waitlist Available
Led By Brent Lanting, BESc, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-operative, 6 weeks
Summary
"This trial aims to study the effects of probiotics on post-menopausal women undergoing knee replacement surgery. The study will compare probiotic use with a placebo to see if probiotics can improve bone quality
Who is the study for?
This trial is for post-menopausal women undergoing primary total knee replacement. It's exploring how a probiotic formula might influence their recovery, bone density, and gut health after surgery.
What is being tested?
The study tests Bacillus subtilis (a probiotic) against a placebo to see if it helps with implant stability, bone quality, and reduces inflammation after knee surgery. Participants won't know which treatment they're getting.
What are the potential side effects?
Probiotics are generally considered safe but may cause digestive upset like gas or bloating in some people. The specific side effects of Bacillus subtilis will be monitored throughout the trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Implant Migration
Secondary study objectives
Bone Density
Magnitude of 18-F-Fluoroethyl(2-(2-fluoroethoxy)phenyl)-proprionate ([¹⁸F]FEPPA) Tracer Uptake
Other study objectives
Diet and Supplement Questionnaire
EuroQol-5D (EQ-5D)
Histopathology
+29 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Probiotic DE111®Experimental Treatment1 Intervention
1 capsule of probiotic DE111® containing 5 billion CFU Bacillus subtilis, to be taken once daily starting 3 weeks prior to surgery until 6 weeks after surgery.
Group II: PlaceboPlacebo Group1 Intervention
1 capsule of placebo, to be taken once daily starting 3 weeks prior to surgery until 6 weeks after surgery.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
681 Previous Clinical Trials
431,310 Total Patients Enrolled
Brent Lanting, BESc, MDPrincipal InvestigatorLawson Health Research Institute